Core Viewpoint - The company, Jianerkang Medical Technology Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, and confirming that there are no false records or significant omissions [1][2]. Financial Data Summary - The financial statements for the third quarter of 2025 are unaudited, covering the period from the beginning to the end of the quarter [3]. - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3]. - The company has not recognized any non-recurring gains or losses that are significant, and there are no changes in the classification of recurring and non-recurring items [3][4]. Shareholder Information - The report does not provide details on the total number of shareholders or any changes in the top ten shareholders due to share lending activities [4]. Financial Statements - The consolidated balance sheet, income statement, and cash flow statement for the period from January to September 2025 have been prepared, but all are unaudited [5]. - The net profit from merged entities prior to consolidation remains at zero for both the current and previous periods [5]. Company Governance - The board of directors and senior management have guaranteed the authenticity and completeness of the quarterly report, taking legal responsibility for its content [2][6].
健尔康医疗科技股份有限公司 2025年第三季度报告